Roberto Dal Pozzolo - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

ACR Open Rheumatology|June 21, 2026

Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I AntibodiesMarta Di Berardino, Pasquale Nigro, Lorenza Bruno, et al.

Rheumatology (Oxford, England)|August 12, 2025

Phenotypic clusters of long-term damage in Sjögren's disease: a 15-year multicentre studyGiacomo Cafaro, Beatrice Dei, Roberto Dal Pozzolo, et al.

Clinical and Experimental Rheumatology|December 27, 2023

Sjögren's syndrome: one year in review 2023Simone Longhino, Loukas G Chatzis, Roberto Dal Pozzolo, et al.

Scientific Reports|May 25, 2026

Distinct molecular profile in Sjögren's syndrome is associated with disease activity and clinical manifestationsCarlo Perricone, Giacomo Cafaro, Martina Nicchi, et al.

Clinical and Experimental Rheumatology|December 18, 2025

Clinical and serological differences of an Italian Sjögren's disease cohort according to three geographic macro-area localisationsFabiola Atzeni, Maria Letizia Currò, Roberto Dal Pozzolo, et al.

Clinical Chemistry and Laboratory Medicine|June 18, 2026

Pre-test probability determines optimal ANA screening strategy: a risk-stratified comparison of indirect immunofluorescence and CTD screen assayGiacomo Cafaro, Francesco Tromby, Andrea Castellucci, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

ACR Open Rheumatology|June 21, 2026

Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I AntibodiesMarta Di Berardino, Pasquale Nigro, Lorenza Bruno, et al.

Rheumatology (Oxford, England)|August 12, 2025

Phenotypic clusters of long-term damage in Sjögren's disease: a 15-year multicentre studyGiacomo Cafaro, Beatrice Dei, Roberto Dal Pozzolo, et al.

Clinical and Experimental Rheumatology|December 27, 2023

Sjögren's syndrome: one year in review 2023Simone Longhino, Loukas G Chatzis, Roberto Dal Pozzolo, et al.

Scientific Reports|May 25, 2026

Distinct molecular profile in Sjögren's syndrome is associated with disease activity and clinical manifestationsCarlo Perricone, Giacomo Cafaro, Martina Nicchi, et al.

Clinical and Experimental Rheumatology|December 18, 2025

Clinical and serological differences of an Italian Sjögren's disease cohort according to three geographic macro-area localisationsFabiola Atzeni, Maria Letizia Currò, Roberto Dal Pozzolo, et al.

Clinical Chemistry and Laboratory Medicine|June 18, 2026

Pre-test probability determines optimal ANA screening strategy: a risk-stratified comparison of indirect immunofluorescence and CTD screen assayGiacomo Cafaro, Francesco Tromby, Andrea Castellucci, et al.

Pageof 2